Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of LRP2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of LRP2 mRNA | affects expression | 21346803
|
C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane results in decreased expression of LRP2 mRNA | decreases expression | 16940010
|
C095105 |
bexarotene |
bexarotene results in decreased expression of LRP2 mRNA | decreases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A affects the expression of LRP2 mRNA | affects expression | 20170705
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of LRP2 mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of LRP2 mRNA | affects expression | 20170705
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of LRP2 mRNA | affects expression | 20170705
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of LRP2 mRNA | decreases expression | 17557909 15834898 16174780 17351261
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of LRP2 mRNA | increases expression | 16940010
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of LRP2 mRNA | decreases expression | 17616710
|
D011374 |
Progesterone |
Progesterone affects the expression of LRP2 mRNA | affects expression | 17251523
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LRP2 mRNA | increases expression | 16467188 15800033
|
D014801 |
Vitamin A |
LRP2 protein results in increased uptake of and affects the abundance of Vitamin A | affects abundance|increases uptake | 16251603
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of LRP2 mRNA | increases expression | 17170073
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 11752688 15322242 14514962 |
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
4.97 | 10992263 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.32 | 11748828 |
MESH:D000740 |
Anemia |
|
Vitamin A |
9.32 | 16960172 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
4.90 | 16960172 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001249 |
Asthma |
|
Vitamin A |
3.38 | 16732791 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
5.17 | 16142846 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.97 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.51 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.40 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
2.00 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.00 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.00 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.00 | 20435547 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
5.75 | 17426644 17377406 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.00 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.00 | 16705839 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.14 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.26 | 16247446 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.82 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.82 | 12371664 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
5.65 | 16153327 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
14.02 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
14.02 | 17681005 17333356 15861022 11677210 16919318 17110522 16105132 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
14.02 | 16175620 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.28 | 15668235 16354765 15340226 12621046 8697196 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
6.28 | 16054864 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
3.06 | 16267017 17219422 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 17632512 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.85 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
2.85 | 10992263 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.36 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.36 | 18551238 |
MESH:D002658 |
Developmental Disabilities |
marker/mechanism |
|
| 17632512 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.54 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.63 | 17187935 |
MESH:C536390 |
Donnai-Barrow syndrome |
marker/mechanism |
|
| |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.34 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.34 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
5.96 | 16146918 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
5.79 | 9068938 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
6.00 | 16054864 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.46 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.46 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.28 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.28 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.80 | 16510608 16704527 15264214 15623463 15878914 16805852 15547733 15547721 15150132 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D015785 |
Eye Diseases, Hereditary |
marker/mechanism |
|
| 17632512 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.95 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.95 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
5.54 | 16054864 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006319 |
Hearing Loss, Sensorineural |
marker/mechanism |
|
| 17632512 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
7.09 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
7.09 | 16080930 10992263 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
marker/mechanism |
|
| 17632512 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
3.65 | 16292552 16877224 17436238 16863852 16490937 15707848 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
3.87 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
5.75 | 17209195 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 18606429 8697196 16354765 15340226 16959395 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18670907 18850075 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
6.34 | 16054864 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.54 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.15 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.15 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.36 | 16393666 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
6.00 | 15955940 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
marker/mechanism |
|
| 17632512 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.40 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.91 | 12371664 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
4.39 | 16054864 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
3.93 | 16256175 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.71 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
2.71 | 16248980 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
3.17 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
5.29 | 16762690 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.49 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.49 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.32 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.32 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
10.32 | 17113696 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
4.16 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
2.56 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.56 | 11884234 19555203 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.28 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
6.60 | 19196722 15591091 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.60 | 11408345 17203775 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
4.13 | 16374440 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.87 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.87 | 7678174 18551238 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.96 | 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.01 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.01 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
4.13 | 17400914 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.23 | 16049721 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.14 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.55 | 16525653 17393432 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
10.03 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.03 | 11118676 11896295 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.32 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.66 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
3.66 | 17024972 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.94 | 10548101 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
5.96 | 16877224 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.89 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.11 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.11 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
3.38 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.43 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.32 | 17575124 12958204 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.14 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.14 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.14 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.51 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.51 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.18 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
5.39 | 16146918 16960172 16175781 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |